Skip to main content

Advertisement

SpringerLink
Log in

In vitro study on intrathecal use of 5-fluoro-2′-deoxyuridine (FdUrd) for meningeal dissemination of malignant brain tumors

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

We investigated 5-fluoro-2′-deoxyuridine (FdUrd) as a potential agent for intrathecal treatment of malignant brain tumors with meningeal dissemination. We examined the neurotoxicity of FdUrd in vitro using primary cultures of neurons from C57BL/6 mice (ED14). Tumoricidal activity was also studied in four glioma cell lines and one medulloblastoma cell line. In addition, thymidine phosphorylase (TPase) and thymidine kinase (TK), which are key enzymes for FdUrd metabolism, were measured in the cerebrospinal fluid (CSF) of 36 patients with brain tumors. The antitumor activity of FdUrd for murine glioma cells was approximately 20- to 200-fold higher than that of 5-fluorouracil (5-FU). Against human cell lines, it was 3- to 500-fold higher than that of 5-FU. The neurotoxic effect of FdUrd on cultured neurons was far less than that of 5-FU or 5-fluorouridine (FUrd). Cerebrospinal fluid contained no detectable thymidine phosphorylase in most patients with brain tumors. Several studies have indicated that FdUrd is rapidly converted to 5-FU in the presence of thymidine phosphorylase, so that a high dose of FdUrd must be administered to obtain good efficacy. However, a high dose FdUrd frequently cause severe toxicity. In contrast, the data obtained here suggest that no enzymatic conversion of FdUrd to 5-FU should occur in the CSF. In addition, FdUrd has an excellent antitumor activity and minimal neurotoxicity. We therefore conclude that intrathecal FdUrd is a potential therapy for CSF dissemination of malignant brain tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. _Hartmann K-U, Heidelberger C: Studies on fluorinated pyrimidines XIII. Inhibition of thymidylate synthetase. J Biol Chem 236: 3006–3013, 1961

    Google Scholar 

  2. Cohen SS, Flaks JG, Barner HD, Loeb MR, Lichtenstein J: The mode of action of 5-fluorouracil and its derivatives. Proc Natl Acad Sci USA 44: 1004–1012, 1958

    Google Scholar 

  3. Laskin JD, Evans RM, Slocum HK, Burke D, Hakala MT: Basis for natural variation in sensitivity to 5-flourouracil in mouse and human cells in culture. Cancer Res 39: 383–390, 1976

    Google Scholar 

  4. Roosa RA, Bradley TD, Law LW, Herzenberg LA: Characterization of resistance to amethopterin, 8-azaguanine and several fluorinated pyrimidines in the murine lymphocytic neoplasm, P388. J Cell Comp Physiol 60: 109–126, 1962

    Google Scholar 

  5. Kanzawa F, Hoshi A, Kuretani K: Differences between 5-fluoro-2′-deoxyuridine and 5-fluorouridine in their cytotoxic effect on growth of murine lymphoma L5178Y cells in in vivo and in vitro systems. Eur J Cancer 16: 1087–1092, 1980

    Google Scholar 

  6. Bosch L, Harbers E, Heidelberger C: Studies on fluorinated pyrimidines. V Effects on nucleic acid metabolism in vitro.Cancer Res 18: 335–343, 1958

    Google Scholar 

  7. Parker WB, Cheng YC: Metabolism and mechanism of action of 5-fluorouracil. Pharmacol Ther 48: 381–395, 1990

    Google Scholar 

  8. Birnie GD, Kroeger H, Heidelberger C: Studies of fluorinated pyrimidines. XVIII. The degradation of 5-fluoro-2′-deoxyuridine and related compounds by nucleoside phosphorylase. Biochemistry 2: 566–572, 1963

    Google Scholar 

  9. Kumanishi T, Ikuta F, Yamamoto T: Brain tumors induced by Rous sarcoma virus, Schmidt-Ruppin strain. III Morphology of brain tumors induced in adult mice. J Natl Cancer Inst 50: 95–109, 1973

    Google Scholar 

  10. Maehara Y, Nakamura H, Nakane Y, Kawai K, Okamoto M, Nagayama S, Shirasaka T, Fujii S: Activities of various enzymes of pyrimidine nucleotide and DNA syntheses in normal and neoplastic human tissues. Gann 73: 289–298, 1982

    Google Scholar 

  11. Kemeny N, Cohen A, Seiter K, Conti JA, Sigurdson ER, Tao Y, Niedzwiecki D, Botet J, Budd A: Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer. J Clin Oncol 11: 330–335, 1993

    Google Scholar 

  12. Marsh JC, Durivage HJ, Davis C, O'Hollaren K, Pasquale DN, Simonich SA, Voynick IM, Bertino JR: Phase II study of pulse 5-fluoro-2′-deoxyuridine and leucovorin in advanced colorectal cancer patients previously treated with chemotherapy. Am J Clin Oncol 15: 115–118, 1992

    Google Scholar 

  13. Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P: Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastasis from colorectal carcinoma. A randomized trial. Ann Int Med 107: 459–465, 1987

    Google Scholar 

  14. Rougier P, Laplanche A, Huguier M, Hay JM, Ollivier JM, Escat J, Salmon R, Julien M, Audy JCR, Gallot D, Gouzi JL, Pailler JL, Elisa D, Lacaine F, Roos S, Ratman N, Luboinski M, Lasser P: Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial. J Clin Oncol 10: 1112–1118, 1992

    Google Scholar 

  15. Roemeling RV, Rabatin JT, Fraley EE, Hrushesky WJM: Progressive metastatic renal cell carcinoma controlled by continuous 5-fluoro-2-deoxyuridine infusion. J Urol 139: 259–262, 1986

    Google Scholar 

  16. Conroy T, Geoffrois L, Guillemin F, Luporsi E, Krakowski I, Spaëth D, Frasie V, Volff D: Simplified chronomodulated continuous infusion of floxuridine in patients with metastatic renal cell carcinoma. Cancer 72: 2190–2197, 1993

    Google Scholar 

  17. Wilkinson MJ, Frye JW, Small EJ, Venook AP, Carroll PR, Ernest ML, Stagg RJ: A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma. Cancer 71: 3601–3604, 1993

    Google Scholar 

  18. Koenig H, Patel A: Biochemical basis for fluorouracil neurotoxicity. Arch Neurol 23: 155–160, 1970

    Google Scholar 

  19. Okeda R, Shibutani M, Matsuo T, Kuroiwa T, Shimokawa R, Tajima T: Experimental neurotoxicity of 5-fluorouracil and its derivatives is due to poisoning by the monofluorinated organic metabolites, monofluoroacetic acid and α-fluoro-β-alanine. Acta Neuropathol 81: 66–73, 1990

    Google Scholar 

  20. Flentje M, Flentje D, Schlag P: Comparison of 5-FU versus FUdr activity in human colorectal cancer using an in vitro clonogenic assay (HTCA). Cancer Chemother Pharmac 18: 223–225, 1986

    Google Scholar 

  21. Koenig H: Neurological action of some pyrimidine analogs. In: Pfeiffer CC, Smythies JR (eds) Internat Rev Neurobiol, Academic Press Inc, New York, 1967, vol 10, pp 199–230

    Google Scholar 

  22. Bryan P: CSF seeding of intracranial tumors: A study of 96 cases. Clin Radiol 25: 355–360, 1974

    Google Scholar 

  23. Giannone L, Greco FA, Hainsworth JD: Combination intraventricular chemotherapy for meningeal neoplasia. J Clin Oncol 4: 68–73, 1986

    Google Scholar 

  24. Wasserstrom WR, Glass JP, Posner JB: Diagnosis and treatment of leptomeningeal metastases from solid tumor: Experience with 90 patients. Cancer 49: 759–772, 1982

    Google Scholar 

  25. Norrell H, Wilson CB, Slagel DE, Clark DB: Leukoencephalopathy following the administration of methotrexate into the cerebrospinal fluid in the treatment of primary brain tumors. Cancer 33: 923–932, 1974

    Google Scholar 

  26. Page KA, Vogel H, Horoupian DS: Intracerebral (parenchymal) infusion of methotrexate: report of a case. J Neurooncol 12: 181–186, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Osaka Medical Center for Cancer & Cardiovascular Diseases (Center for Adult Diseases, Osaka), Osaka

    Masanobu Yamada & Hidemitsu Nakagawa

  2. Department of Neurosurgery, Osaka University Medical School, Osaka

    Keiji Shimizu & Toru Hayakawa

  3. Laboratory of Neural Information, National Institute for Physiological Sciences, Okazaki National Research Institutes, Okazaki, Aichi, Japan

    Kazuhiro Ikenaka

Authors
  1. Masanobu Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hidemitsu Nakagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masakazu Fukushima
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Keiji Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Toru Hayakawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kazuhiro Ikenaka
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamada, M., Nakagawa, H., Fukushima, M. et al. In vitro study on intrathecal use of 5-fluoro-2′-deoxyuridine (FdUrd) for meningeal dissemination of malignant brain tumors. J Neurooncol 37, 115–121 (1998). https://doi.org/10.1023/A:1005869226496

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005869226496

Search

Navigation